Skip to main content
OpenTrials

Clinical trial condition

Turcot syndrome

Explore clinical trials studying Turcot syndrome. Study availability and eligibility vary by location and protocol.

49 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Turcot syndrome trial results

Active, not recruiting

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma

NCT02359565

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +46 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View Trial Details
Active, not recruiting

Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.

NCT05838768

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +14 more
Locations
  • University of California LA Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering New York, United States
View all 28 locations
View Trial Details
Active, not recruiting

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)

NCT03767348

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • University of Birmingham Alabama Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • Carti Cancer Center Little Rock, Arkansas, United States
View all 51 locations
View Trial Details
Active, not recruiting

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

NCT06710847

Conditions
Colon Cancer, Colonic Diseases, Colonic Neoplasms, +26 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site New York, United States
View all 22 locations
View Trial Details
Active, not recruiting

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

NCT03228667

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +79 more
Locations
  • Alaska Clinical Research Center Anchorage, Alaska, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Chan Soon-Shiong Institute for Medicine El Segundo, California, United States
  • MemorialCare Health System Fountain Valley, California, United States
View all 35 locations
View Trial Details

Related conditions